BNTX technical analysis

BNTX Technical Analysis

Analysis date

July 17, 2026

Market

NasdaqGS (USD)

Daily cutoff

July 16, 2026

Reliability

Passed

Informational use only. This page is not investment advice.

Data verification

BNTX Data Verification

Cross-validating the latest completed daily bar across independent sources.

Symbol
BNTX
Market
NasdaqGS
Currency
USD (US Dollar)
Latest completed bar
July 16, 2026

No adjustment factor (adjusted close equals raw close, factor 1.0). No stock splits or dividend adjustments affecting the analysis period.

SourceLatest CloseDateDifferenceStatus
Yahoo Finance Chart API (primary)85.60July 16, 2026-Verified
Finviz (independent)85.60July 16, 2026 (previous close)0.00%Verified

Bottom line

BNTX Technical Analysis Summary

BNTX (BioNTech) presents a challenging technical picture as the stock continues to trade near its post-pandemic lows. At 85.60, price is below all major SMAs on both the daily and weekly timeframes, confirming a sustained downtrend. The daily RSI14 at 42.31 is below the 50 midline, indicating bearish momentum, though not in oversold territory. The daily MACD is negative with the MACD line at -1.84 below the signal line at -1.35, and the histogram at -0.49 is expanding downward, suggesting momentum continues to weaken. Key support lies at the 52-week low of 78.00. Resistance levels cluster around SMA20 (91.45) and the 60-day high of 102.90. A sustained move above 102.90 would be needed to suggest a meaningful trend reversal.

Multi-timeframe dashboard

Multi-Timeframe Technical Dashboard

Comparing daily (2-year) and weekly (5-year) perspectives to identify aligned or conflicting signals.

Daily (July 16, 2026)

Trend
Bearish. Price at 85.60 is below SMA20 (91.45, -6.40%), SMA50 (97.32, -12.04%), and SMA200 (93.78, -8.72%). All three major SMAs are declining, with SMA20 crossing below SMA50 in a bearish formation. The stock has been making lower lows and lower highs since the January 2026 peak near 130.
Momentum
Bearish. RSI14 at 42.31 is below the 50 midline, confirming bearish momentum. MACD line at -1.84 is below the signal line at -1.35, and the histogram at -0.49 is in negative territory and expanding — indicating deteriorating momentum. There is no bullish divergence visible.
Volatility
Moderate. ATR14 at 2.89 (3.38% of price) suggests average daily movement of about 3.4%. Bollinger Bands (80.61 to 101.79) show price trading near the lower band, consistent with the current downtrend. Band width is normal, indicating no volatility contraction or expansion.
Volume
Slightly below average. Latest volume of 1,245,800 is 82.3% of the 20-period average (1,513,400), indicating below-average participation. The lack of elevated volume on down days suggests the selling pressure is not accelerating, but buying interest remains absent.

Assessment

The daily chart paints a bearish picture for BNTX. Price is below all key moving averages with a bearish alignment. RSI below 50 and a negative, expanding MACD histogram all point to continued downside risk. The stock has given up the gains from the mid-2025 bounce and is testing levels near the 52-week low. The lack of volume spikes on down days is the only moderately positive sign, suggesting orderly decline rather than panic selling. A test of the 78.00 support level appears increasingly likely unless buying volume materializes.

Weekly (July 13, 2026 week)

Trend
Bearish. Price at 84.15 is below SMA20 (99.51), SMA50 (115.32), and SMA200 (118.76). All weekly SMAs are sloping downward with no signs of flattening. The weekly chart shows a persistent downtrend since the December 2024 high of 138.50.
Momentum
Bearish. Weekly RSI14 at 39.84 is below 50, confirming the bearish momentum at the weekly level. MACD line at -3.45 is well below the signal line at -2.18, with the histogram at -1.27 continuing to expand negatively — bearish momentum is intact and not showing signs of exhaustion.
Volatility
Moderate. Weekly ATR14 at 5.62 (6.68% of price) reflects normal weekly ranges for a biotech stock. Bollinger Bands (75.50 to 128.40) are wide, with price hugging the lower band — a reflection of persistent selling pressure.
Volume
Above average. Weekly volume of 6,214,500 is 115.8% of the 20-week average (5,365,800), indicating elevated participation in the decline. Higher volume on down weeks confirms distribution.

Assessment

The weekly timeframe reinforces the bearish picture. Price is firmly below all major moving averages, and momentum indicators are uniformly bearish without divergence. The elevated volume on the decline suggests institutional distribution rather than a retail-driven move. The stock is approaching the 78.00 support area, a level that held during the October 2023 lows. A break below this level would open the door to further downside toward the 68.00 area.

Key indicators

BNTX Key Technical Indicators

RSI, MACD, moving averages, ATR, and Bollinger Bands across daily and weekly timeframes.

IndicatorDailyWeekly
RSI (14)42.3139.84
MACD (12, 26, 9)-1.84 / -1.35 / -0.49-3.45 / -2.18 / -1.27
ATR (14)2.89 (3.38%)5.62 (6.68%)
Bollinger Bands (20, 2)80.61 - 101.7975.50 - 128.40
SMA (20)91.4599.51
SMA (50)97.32115.32
SMA (200)93.78118.76

Price structure

BNTX Price Structure and Returns

Price performance across multiple lookback periods and 52-week position.

MetricDailyWeekly
Current Price85.6084.15
1-Period Return-1.04%-2.20%
5-Period Return-4.25%-6.50%
20-Period Return-6.80%-14.30%
60-Period Return-12.50%-25.40%
252-Period Return-32.10%-36.80%
52-Week Low78.0078.00
52-Week High138.50138.50
52-Week Position12.40%10.70%

Key levels

BNTX Support and Resistance Levels

Key price levels based on recent swing highs and lows across daily and weekly timeframes.

LevelDailyWeekly
20-Period High102.90116.50
20-Period Low78.0078.00
60-Period High115.80138.50
60-Period Low78.0078.00

Scenarios

BNTX Technical Scenarios

Conditions, invalidation triggers, and what to watch for each scenario.

Bullish

Trigger

Price reclaims SMA20 (91.45) on above-average volume and establishes support above 90.00. RSI climbing back above 50 would confirm the shift.

Invalidation

Price fails at SMA20 resistance and breaks below the 52-week low at 78.00.

What to watch

Daily RSI crossing above 50; MACD histogram turning less negative; volume picking up on green days; weekly RSI holding above 35 without making a new low.

Range-Bound

Trigger

Price oscillates between 78.00 support and SMA20 resistance (91.45) with no clear directional bias. RSI fluctuating between 35 and 50.

Invalidation

A decisive break above 102.90 or below 78.00 with expanding volume.

What to watch

RSI staying in the 35-50 zone; MACD histogram oscillating around zero; volume remaining near average; price respecting both range boundaries.

Bearish

Trigger

Price breaks below the 52-week low at 78.00 with above-average volume, opening the path toward the next support zone near 68.00.

Invalidation

Price holds above 78.00 and reclaims SMA20 (91.45) within two weeks.

What to watch

Daily RSI falling below 35; MACD histogram expanding further negative; volume accelerating on breakdown; weekly MACD remaining deep in negative territory.

Methodology

Methodology and Limitations

This technical analysis uses adjusted closing prices from Yahoo Finance (primary) and Finviz (independent cross-validation). The daily analysis covers approximately 2 years (501 completed bars) ending July 16, 2026. The weekly analysis covers approximately 5 years (261 completed bars) ending the week of July 13, 2026. Prices are adjusted for dividends and stock splits using the adjusted close/raw close ratio. Volume data is from the primary source and may not match other data providers. Technical indicators include SMA, RSI, MACD, ATR, and Bollinger Bands using standard parameters. Key levels are identified from recent swing highs and lows. Technical analysis studies historical price patterns and does not constitute investment advice. It should not be used as the sole basis for trading decisions.

Frequently Asked Questions

This technical analysis is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. Past performance and historical patterns are not guarantees of future results. All investments carry risk, including the potential loss of principal. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Data sourced from Yahoo Finance (primary) and Finviz (independent cross-validation). Data cutoffs: daily July 16, 2026, weekly July 13, 2026 week. Generated July 17, 2026.